Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
952 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01223027 | Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma | completed | Phase 3 | 564 | Novartis PharmaceuticalsINDUSTRY | 27 | Dec 7, 2015 | clinicaltrials |
| NCT00409188 | Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)(START) | completed | Phase 3 | 1,513 | EMD SeronoINDUSTRY | 33 | Nov 20, 2015 | clinicaltrials |
| NCT00085163 | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Oct 20, 2015 | clinicaltrials |
| NCT00103506 | Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma | completed | Phase 3 | 646 | Janssen Research & Development, LLCINDUSTRY | 17 | Oct 19, 2015 | clinicaltrials |
| NCT00373425 | A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors(RADIANT) | completed | Phase 3 | 1,252 | OSI PharmaceuticalsINDUSTRY | 19 | Sep 17, 2015 | clinicaltrials |
| NCT00528567 | BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer | completed | Phase 3 | 2,591 | Hoffmann-La RocheINDUSTRY | 40 | Sep 4, 2015 | clinicaltrials |
| NCT00256932 | Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | completed | Phase 3 | 518 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 10 | Sep 2, 2015 | clinicaltrials |
| NCT00391092 | A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 16 | Aug 28, 2015 | clinicaltrials |
| NCT00440310 | Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases | completed | Phase 3 | 483 | Light Sciences OncologyINDUSTRY | 13 | Aug 25, 2015 | clinicaltrials |
| NCT00293124 | Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors | completed | Phase 3 | 125 | Central European Cooperative Oncology GroupOTHER | 10 | Aug 13, 2015 | clinicaltrials |
| NCT01014208 | Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma(ORCHARRD) | completed | Phase 3 | 447 | GlaxoSmithKlineINDUSTRY | 26 | Aug 7, 2015 | clinicaltrials |
| NCT00003636 | Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer | completed | Phase 3 | 704 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 15 | Aug 5, 2015 | clinicaltrials |
| NCT00700102 | A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 820 | Hoffmann-La RocheINDUSTRY | 15 | Jul 30, 2015 | clinicaltrials |
| NCT02076815 | Anagrelide Retard in Essential Thrombocythemia(TEAM-ET) | completed | Phase 3 | 106 | AOP Orphan Pharmaceuticals AGINDUSTRY | 5 | Jul 29, 2015 | clinicaltrials |
| NCT01423500 | ALL-SCT BFM International- HSCT in Children and Adolescents With ALL(ALL-SCT-BFMi) | unknown | Phase 3 | 405 | St. Anna KinderkrebsforschungOTHER | 11 | Jun 26, 2015 | clinicaltrials |
| NCT01423747 | Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia | unknown | Phase 3 | 400 | St. Anna KinderkrebsforschungOTHER | 2 | Jun 26, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT00075270 | Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer | completed | Phase 3 | 580 | GlaxoSmithKlineINDUSTRY | 25 | May 6, 2015 | clinicaltrials |
| NCT00117598 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)(OPTIMAL) | completed | Phase 3 | 169 | PfizerINDUSTRY | 18 | Mar 30, 2015 | clinicaltrials |
| NCT00254904 | Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC | terminated | Phase 3 | 839 | PfizerINDUSTRY | 24 | Mar 30, 2015 | clinicaltrials |
| NCT00457691 | Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 768 | PfizerINDUSTRY | 34 | Mar 30, 2015 | clinicaltrials |
| NCT00512993 | Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy(NATAN) | completed | Phase 3 | 654 | GBG Forschungs GmbHOTHER | 2 | Mar 5, 2015 | clinicaltrials |
| NCT00556322 | A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 27 | Feb 23, 2015 | clinicaltrials |
| NCT00556712 | A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 889 | Hoffmann-La RocheINDUSTRY | 28 | Feb 11, 2015 | clinicaltrials |
| NCT01254279 | Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen | completed | Phase 3 | 984 | SanofiINDUSTRY | 29 | Jan 21, 2015 | clinicaltrials |
| NCT00863746 | A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).(MISSION) | completed | Phase 3 | 703 | BayerINDUSTRY | 34 | Jan 19, 2015 | clinicaltrials |
| NCT00484939 | A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 280 | Hoffmann-La RocheINDUSTRY | 12 | Jan 8, 2015 | clinicaltrials |
| NCT00102804 | Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 663 | Eli Lilly and CompanyINDUSTRY | 20 | Dec 29, 2014 | clinicaltrials |
| NCT00306137 | Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer | terminated | Phase 3 | 104 | BayerINDUSTRY | 10 | Dec 9, 2014 | clinicaltrials |
| NCT01650805 | Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC) | terminated | Phase 3 | 307 | Ariad PharmaceuticalsINDUSTRY | 24 | Nov 17, 2014 | clinicaltrials |
| NCT00761280 | Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma(SAPPHIRE) | terminated | Phase 3 | 27 | Isarna Therapeutics GmbHINDUSTRY | 16 | Nov 14, 2014 | clinicaltrials |
| NCT00123487 | Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML | completed | Phase 3 | 638 | Bristol-Myers SquibbINDUSTRY | 32 | Nov 3, 2014 | clinicaltrials |
| NCT00324155 | Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma | completed | Phase 3 | 681 | Bristol-Myers SquibbINDUSTRY | 25 | Nov 3, 2014 | clinicaltrials |
| NCT01998906 | A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer | completed | Phase 3 | 330 | Hoffmann-La RocheINDUSTRY | 6 | Oct 28, 2014 | clinicaltrials |
| NCT00061984 | Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 3 | 455 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Oct 27, 2014 | clinicaltrials |
| NCT00384891 | Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer | terminated | Phase 3 | 190 | Medical Enterprises Europe B.V.INDUSTRY | 4 | Oct 7, 2014 | clinicaltrials |
| NCT01214720 | A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer | completed | Phase 3 | 607 | Hoffmann-La RocheINDUSTRY | 21 | Aug 13, 2014 | clinicaltrials |
| NCT00002641 | Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | completed | Phase 3 | 350 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT01189253 | Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma | terminated | Phase 2 / Phase 3 | 133 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT00925548 | STRIDE - STimulating Immune Response In aDvanced brEast Cancer(STRIDE) | terminated | Phase 3 | 16 | EMD SeronoINDUSTRY | 12 | Jul 24, 2014 | clinicaltrials |
| NCT00122460 | Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | completed | Phase 3 | 442 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 17 | Jul 23, 2014 | clinicaltrials |
| NCT00678535 | Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer(EXPAND) | completed | Phase 3 | 904 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 25 | Jul 21, 2014 | clinicaltrials |
| NCT00424255 | Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery | completed | Phase 3 | 688 | GlaxoSmithKlineINDUSTRY | 22 | Jul 18, 2014 | clinicaltrials |
| NCT00148798 | Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)(FLEX) | completed | Phase 3 | 1,861 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 28 | Jun 25, 2014 | clinicaltrials |
| NCT00638690 | Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | completed | Phase 3 | 1,195 | Cougar Biotechnology, Inc.INDUSTRY | 12 | Apr 30, 2014 | clinicaltrials |
| NCT00086580 | Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients | completed | Phase 3 | 335 | Genzyme, a Sanofi CompanyINDUSTRY | 15 | Mar 13, 2014 | clinicaltrials |
| NCT00015873 | Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia | completed | Phase 3 | 350 | Dutch Childhood Oncology GroupOTHER | 11 | Feb 17, 2014 | clinicaltrials |
| NCT00387764 | Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer | completed | Phase 3 | 80 | GlaxoSmithKlineINDUSTRY | 20 | Jan 14, 2014 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials